Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 7, 2019; 25(33): 4985-4998
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4985
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4985
Table 1 Primers and LNA probes developed for identification of hepatitis B virus wild type (YMDD) and rtM204I variants (YIDD) by real-time PCR
- Citation: Choe WH, Kim K, Lee SY, Choi YM, Kwon SY, Kim JH, Kim BJ. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations. World J Gastroenterol 2019; 25(33): 4985-4998
- URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4985.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i33.4985